The forecast for the import of Penicillins or Streptomycins not in dosage forms to Canada indicates a declining trend from 2024 to 2028, with values projected to decrease from 348.52 to 306.69 thousand USD. When compared to 2023 levels, these figures suggest a consistent year-on-year decrease, reflecting an annual compound decrease that averages over the forecast period.
Future trends to watch for include:
- The impact of global supply chain dynamics, which may affect availability and cost.
- Potential shifts in Canada's demand for these pharmaceuticals due to evolving healthcare needs or policy changes.
- Technological advancements in drug formulation and distribution that could influence import patterns.
